These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 483262)

  • 1. Thrombin accelerating factor in various urokinase preparations.
    Takada A; Matsuda H; Urano T; Takada Y
    Thromb Res; 1979; 14(4-5):673-8. PubMed ID: 483262
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of urokinase upon euglobulin lysis time and thrombin time.
    Lee TK; Huang SC; Lin SA; Chien LM
    Taiwan Yi Xue Hui Za Zhi; 1976 Mar; 75(03):190-7. PubMed ID: 1066436
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrinogen-fibrin related antigen pattern in human blood. Incomplete lysis of whole blood clots by urokinase.
    Jacobsen CD; Fry GL; Wu KK; Southers NJ
    Thromb Res; 1975 Apr; 6(4):327-36. PubMed ID: 1079637
    [No Abstract]   [Full Text] [Related]  

  • 4. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.
    Thorsen S; Astrup T
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):306-24. PubMed ID: 4281113
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation of Glu-plasminogen by urokinase in the presence of fibrinogen, fibrin, and SK-potentiator.
    Takada A; Takada Y
    Thromb Res; 1981 May; 22(4):497-501. PubMed ID: 6457416
    [No Abstract]   [Full Text] [Related]  

  • 6. Dissolution of thrombi by tissue plasminogen activator, urokinase and streptokinase in an artificial circulating system.
    Mattsson C; Nyberg-Arrhenius V; Wallén P
    Thromb Res; 1981 Mar; 21(6):535-45. PubMed ID: 7022741
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of coagulation on the activation of plasminogen by streptokinase and urokinase.
    Takada A; Urano T; Takada Y
    Thromb Haemost; 1979 Oct; 42(3):901-8. PubMed ID: 505405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation and importance of the clot-promoting potential of urokinase].
    Morito T; Kuto M; Wada H; Urata T; Lee CJ; Deguchi K; Shirakawa S
    Nihon Ketsueki Gakkai Zasshi; 1983 May; 46(3):759-66. PubMed ID: 6351526
    [No Abstract]   [Full Text] [Related]  

  • 9. Variations of alpha 2-plasmin inhibitor, antithrombin III, plasminogen in the serum of patients of cerebral thrombosis infused with urokinase.
    Takada A; Takada Y; Uemura K; Nakajima S; Ryu H; Ninchoji T
    Thromb Res; 1979; 15(5-6):889-94. PubMed ID: 115108
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of tranexamic acid, cis-AMCHA, and 6-aminohexanoic acid on the activation rate of plasminogen by urokinase in the presence of clot.
    Takada A; Ohashi H; Matsuda H; Takada Y
    Thromb Res; 1979; 14(6):915-23. PubMed ID: 473126
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Fibrinolysis versus fibrinogenolysis: the specificity of human vascular activator (VA) as compared to urokinase (UK) and streptokinase (SK).
    Lipinski B; Gurewich V; Hyde E
    Thromb Diath Haemorrh; 1975 Sep; 34(1):351. PubMed ID: 1188799
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibitory effect of decidua on fibrinolysis induced by urokinase and by the fibrinolytic activity of the rat ovum.
    Liedholm P; Astedt B
    Acta Obstet Gynecol Scand; 1976; 55(3):217-9. PubMed ID: 936985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of fibrin on the enhanced activation of plasminogen by urokinase and tissue plasminogen activator: role of cross-link.
    Takada A; Watahiki Y; Takada Y
    Thromb Res; 1986 Mar; 41(5):605-13. PubMed ID: 3083529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase-induced fibrin clot lysis and its inhibition by plasma.
    Carlin G
    Ups J Med Sci; 1980; 85(1):29-33. PubMed ID: 6446181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor XIII cross-linking and the rate of fibrinolysis induced by streptokinase and urokinase.
    Rampling MW
    Thromb Res; 1978 Feb; 12(2):287-95. PubMed ID: 635844
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thrombolytic therapy using urokinase in cerebral thrombosis (author's transl)].
    Sakuragawa N
    Nihon Naika Gakkai Zasshi; 1979 May; 68(5):486-9. PubMed ID: 469353
    [No Abstract]   [Full Text] [Related]  

  • 17. Leukocyte-plasma interaction in fibrinolysis. A new dimension in the action of urokinase.
    Moroz LA; Sniderman AD; Marpole DG
    N Engl J Med; 1979 Nov; 301(20):1100-4. PubMed ID: 158709
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of urokinase on growth and metastases of rabbit V2 carcinoma.
    Kodama Y; Tanaka K
    Gan; 1978 Feb; 69(1):9-18. PubMed ID: 640328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective study on the efficacy of using urokinase therapy.
    Matsuo O; Kosugi T; Mihara H; Ohki Y; Matsuo T
    Nihon Ketsueki Gakkai Zasshi; 1979 Aug; 42(4):684-8. PubMed ID: 506651
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.
    Shenkman B; Livnat T; Budnik I; Tamarin I; Einav Y; Martinowitz U
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):729-33. PubMed ID: 22918041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.